According to Wall Street analyst, Abbott Laboratories stock could rise to $143. Is it a buy at around $108?

According to an optimistic Wall Street analyst Abbott Laboratories (NYSE: ABT) Stock could deliver better performance for investors. Following the company’s latest earnings report, Matt Miksic of Barclays maintained its buy rating and raised its price target to $143 per…